Planet 13 Announces Q3 2026 Financial Results

Planet 13 Holdings Inc. (PLNH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Planet 13 Announces Q3 2026 Financial Results ● Q3 2026 Revenue of $23.1 million ● Q3 2026 Net loss of $6.4 million ● Q3 2026 Adjusted EBITDA loss of $0.2 million All figures are reported in United States dollars ($) unless otherwise indicated Las Vegas, Nevada – Nov

Event · Earnings
Original reporting
Published Nov 12, 2026, 9:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PLNH
Bearish
high confidence
Mentioned
$PLNH
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PLNHBearishMed
01

Why it matters

The earnings release provides fresh data on revenue trends and loss narrowing, which will influence the upcoming shareholder vote on the merger.

02

Market read

Primary earnings disclosure for a small‑cap cannabis stock; relevant for traders tracking sector performance and merger outcomes.

03

What to watch

Cash balance of $15.7M and cost reductions suggest the company may sustain operations through the merger vote period.

Relevance 7/10Novelty 6/10Timing: after‑hours filing on Nov 12 2026

Background

Planet 13 is a multi‑state cannabis operator that recently announced a merger with Vireo Growth; the filing includes the first public release of Q3 2026 numbers.

Company-level read

Ticker impact

$PLNHBearishHigh confidence
Context

Planet 13 Holdings filed its Q3 2026 earnings on Form 8‑K, reporting $23.1M revenue, a $6.4M net loss and adjusted EBITDA loss of $0.2M.

Expected impact

likely modest downside as the net loss remains sizable despite improvement

Evidence & confidence

The primary disclosure of quarterly results provides fresh data; the loss reduction is positive but still a loss, which typically pressures the stock.

Market effects

Shows continued pressure on the U.S. cannabis sector with mixed state‑level performance.

Florida operations drive revenue growth, while Nevada tourism weakness drags results.

Limited to cannabis investors; no broader market effect.

Counterpoint

The merger with Vireo Growth could unlock scale and improve margins, making the stock a longer‑term buy despite the short‑term loss.

Key entities

  • Planet 13 Holdings Inc.

    U.S. cannabis operator reporting Q3 2026 results.

  • Vireo Growth Inc.

    Merger partner; its Form S‑4 was declared effective.

Related articles

$PLNHMed

Planet 13 Announces Q2 2026 Financial Results

Planet 13 Holdings Inc. (PLNH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Planet 13 Announces Q2 2026 Financial Results ● Q2 2026 Revenue of $22.9 million ● Q2 2026 Net loss of $5.6 million ● Q2 2026 Adjusted EBITDA loss of $0.5 million All figures are reported in United States dollars ($) unless otherwise indicated Las Vegas, Nevada – Aug

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.

$YTRAMed

Yatra Online Inc (YTRA) (Q2 2027) Earnings Call Highlights: Air and Corporate Travel

Yatra Online (YTRA) reported Q2 2027 revenue from operations down 39% YoY to INR2,136M (~$22M) due to lower MICE volumes. Gross margin stayed flat at INR1,255M (~$13M). Adjusted EBITDA swung to negative INR32M (~negative $0.3M). CEO Gupta noted MICE recovery signs, TravelPro and Recap initiatives progress, and AI efficiency gains. Standalone hotels grew 20% YoY. H1 FY27 revenue declined 28% YoY to INR4,015M (~$42M).